English | Español
Patient Daily | Mar 22, 2026

Biopharma industry draws lessons from Formula 1 on precision and partnership
Patient Daily | Mar 22, 2026

Sana’s cell therapy sustains insulin production through 14 months in a T1D patient
Patient Daily | Mar 22, 2026

BioMarin pauses dosing and enrollment in two Voxzogo studies after safety signal
Patient Daily | Mar 22, 2026

FDA rejects REGENXBIO’s Hunter syndrome therapy as Denali awaits decision on rival drug
Patient Daily | Mar 22, 2026

Structure Therapeutics reports competitive results for oral weight loss drug in Phase 2 study
Patient Daily | Mar 22, 2026

White House urges Kennedy to shift vaccine stance as election approaches
Patient Daily | Mar 22, 2026

Expert discusses impact of reality TV disclosures on sexual trauma healing
Patient Daily | Mar 22, 2026

Penn researchers receive up to $7.8 million for lymphatic system imaging project

Trending
+ Pharmaceuticals
Patient Daily | Mar 16, 2026

Five therapies show progress in multiple myeloma treatment landscape
+ Regulatory
B. D. Benavides | Mar 18, 2026

Taxpayer advocate: Instead of improving product safety, litigation can result in the ‘opposite because runaway legal costs deter innovation'
+ Pharmaceuticals
Patient Daily | Mar 16, 2026

FDA advisory committee to review two AstraZeneca cancer drugs in April meeting
+ Pharmaceuticals
Patient Daily | Mar 16, 2026

FDA biologics director Vinay Prasad to depart in April, analysts predict impact on biotech